Literature DB >> 6426401

[Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].

H Nakamura, W Yu-Qin, S Miyauchi, N Nishioka, H Tanaka, N Harada, T Shirasaka, S Fujii.   

Abstract

The relationship between the antitumor activity and the inhibition of thymidylate synthase after oral administration of 5-FU, FT-207 or UFT was examined. The inhibition of tumor growth on sarcoma-180 after oral administration of 5-FU (20 mg/kg), FT-207 (120 mg/kg) or UFT (30 mg/kg) was 40%, 50% or 70%, respectively. It was found that the inhibition of thymidylate synthase in sarcoma-180 tumor tissue after single oral administration of 5-FU (20 mg/kg), FT-207 (30 or 120 mg/kg) or UFT (30 mg/kg) were about 45%, 20%, 50% or 65%, respectively, but the activities of other enzymes involved in DNA synthesis were not almost inhibited. Thymidylate synthase was inhibited more severely by oral administration of UFT (30 mg/kg). The activities of other enzymes were not inhibited even by continuous oral administration of these drugs for 6 or 11 days. The extent of inhibition of thymidylate synthase seemed to be parallel to that of inhibition of tumor growth. These results suggest that the inhibition of thymidylate synthase by FdUMP converted from 5-FU, FT-207 or UFT plays a major role in their antitumor actions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426401

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

1.  A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer.

Authors:  T Inada; Y Ogata; T Kubota; I Ozawa; S Hishinuma; H Shimizu; K Kotake; T Ikeda; Y Koyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells.

Authors:  Zhuo Liu; Miao Yu; Bingyuan Fei; Jing Sun; Dongxin Wang
Journal:  Drug Des Devel Ther       Date:  2019-11-06       Impact factor: 4.162

3.  Antitumor activity of fluoropyrimidines and thymidylate synthetase inhibition.

Authors:  T Kubota; S Fujita; S Kodaira; T Yamamoto; K Josui; Y Arisawa; A Suto; K Ishibiki; O Abe; K Mabuchi
Journal:  Jpn J Cancer Res       Date:  1991-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.